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Abstract
Background: There are relatively few standard, objective measures for studying physical function among older adults
with multiple sclerosis (MS), yet such measures are necessary considering the shift in prevalence and associated
consequences of both MS and older age on physical function. We undertook a preliminary examination of the
construct validity of Short Physical Performance Battery (SPPB) scores in older adults with MS based on an expected
differential pattern of associations with measures of lower and upper extremity function.
Methods: The sample included 48 persons with MS aged 50 years and older who were enrolled in a pilot, randomized
controlled trial of exercise training. Participants completed the SPPB and other objective and self-report measures of
lower and upper extremity function as part of baseline testing.
Results: SPPB scores demonstrated strong associations with measures of lower extremity function (|rs| = .66–.79), and
weak associations with measures of upper extremity function (|rs| = .03–.33).
Conclusions: We provide preliminary evidence that supports the validity of scores from the SPPB as a measure of
lower extremity function for inclusion in clinical research and practice involving older adults with MS.
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Background
Of the estimated 400,000 adults living with multiple
sclerosis(MS) in the United States, 32 % are between the
ages of 55–64 years and 14 % are 65 years of age or older
[1]. There is additional evidence of a shift in the peak
prevalence of MS among older age groups of adults (i.e.,
women 45–59 years of age and men 55–69 years of age)
[2]. Importantly, this cohort undergoes normal age-related
changes in function (e.g., ambulatory and balance dysfunc-
tion and leg muscle weakness) as well as those associated
with MS and its progression [3]. Older adults with MS re-
port limitations with both basic and instrumental activities
of daily living [4], have accelerated rates of neurological
disability progression [5], and express concerns about con-
tinuing loss of function and mobility with aging [6, 7].
Such observations underscore the importance of studying
physical function among older adults with MS in both
clinical and research settings.
There are relatively few standard, objective measures for
studying physical function among older adults with MS,
and we believe that the Short Physical Performance Bat-
tery (SPPB) holds considerable promise as such an out-
come assessment. The SPPB was developed as an
objective measure for evaluating lower extremity function
in older adults [8]. The SPPB includes assessments of bal-
ance, gait speed, and lower extremity strength, and those
functions are compromised with the intersection of MS
and aging. This battery can be administered easily,
quickly (10 min), and uniformly in a variety of contexts by
researchers and clinicians who complete a short course of
training [9]. There is a standard system for scoring per-
formance on the three assessments and those scores are
aggregated into a summary SPPB score. The summary
SPPB score has been associated with nursing home
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administration and mortality, as well as mobility and
disability over a four-year period in community-dwelling
older adults [8, 10]. Additionally, the SPPB has been in-
cluded as a performance measure in hospitalized older
adults [11] and clinical trials of exercise training among
older adults [12], and has been recognized as the best
performance-based measure of physical function for
community-dwelling older adults [13].
The existing research on physical function in older
adults with MS has included self-report measures [4, 6]
and these seemingly have problems with validity, reprodu-
cibility, sensitivity to change, and applicability for cross-
cultural and cross-national studies, as noted for normal
aging populations [14]. To that end, we examined the con-
struct validity (i.e., convergent and divergent validity) of
SPPB scores in older adults with MS based on an expected
pattern of correlations with objective and self-report
measures of lower and upper extremity function. Conver-
gent validity was based on expected strong correlations
with measures of lower extremity function (i.e., 6-min
walk [6 MW] [15], timed 25-foot walk [T25FW] [16],
Multiple Sclerosis Walking Scale-12 [MSWS-12] scores
[17], and the abbreviated Late-Life Function and Disability
Instrument [LLFDI] basic [BLEF] and advanced lower
extremity function [ALEF] subscale scores[18]). Divergent
validity was based on expected weak correlations with
measures of upper extremity function (i.e., arm curls,




This paper involves a secondary analysis of baseline data
from a recently completed pilot, randomized controlled
trial (RCT) of a 6-month, DVD-delivered exercise inter-
vention in older adults with MS [19, 20]. The registra-
tion number of the original trial was NCT01993095. The
sample included 48 persons with MS aged 50 years and
older [6] who were recruited from within a 50-mile
radius of Champaign-Urbana, IL. We recruited partici-
pants from a mailing list of persons with MS in Illinois,
a database of previous research volunteers, and a re-
search advertisement posted on the website of the
Greater Illinois chapter of the National Multiple Sclerosis
Society (NMSS). The advertisements informed potential
participants of a free, programmatic home-based exercise
program that targets flexibility, strength, balance, and mo-
bility in older adults with MS. The inclusion criteria for
participation were: (a) definite diagnosis of MS that was
confirmed in writing by the patient’s neurologist; (b) re-
lapse free in the last 30 days; (c) ambulatory with or with-
out assistance (i.e., walk independently or walk with a
cane/rollator); (d) capable of engaging in systematic exer-
cise without exacerbating any existing condition;
Fig. 1 Scatter plots of the association between Short Physical Performance Battery(SPPB) scores and Timed 25–‐Foot Walking (T25FW), 6–‐Minute
Walk (6 MW), Multiple Sclerosis Walking Scale–‐12 (MSWS–‐12), Late–‐Life Function and Disability Instrument, Advanced Lower Extremity Function
Subscale (LLFDI–‐ALEF), and Late–‐ Life Function and Disability Instrument, Basic Lower Extremity Function Subscale (LLFDI–‐BLEF)scores
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(e) clearance for participation in physical activity by per-
sonal physician; (f) physical inactivity defined as two or
fewer days of exercise per week over previous 6 months;
(g) Expanded Disability Status Scale (EDSS) [21] score of
6.5 or less(i.e., constant bilateral assistance); and (h) and
Modified Telephone Interview for Cognitive Status score
above 21 [22]. All participants provided written informed
consent before participating in the study.
Measures
The complete list of outcomes from the parent RCT has
been reported elsewhere [20], and we included selected
measures for establishing convergent and divergent con-
struct validation of SPPB scores. Importantly, the partici-
pants were permitted to use canes and walkers during
the SPPB as well as all assessments involving lower
extremity function (e.g., T25FW & 6 MW).
SPPB
The SPPB assesses lower extremity function based on a
three-part assessment, including standing balance, gait
speed, and lower extremity strength [8–10]. Standing
balance was assessed by asking participants to maintain
upright posture for up to 10 s per test while standing
with feet in side-by-side, semi-tandem, and tandem posi-
tions. Those balance assessments occurred in a progres-
sive order wherein participants passed one test in order
to attempt the subsequent, more challenging test. Gait
speed was assessed based on the time taken by a partici-
pant to walk a four-meter course at a normal pace.
Lower extremity strength was assessed by a chair stand
test in which participants were instructed to sit in and
fully rise from a chair five times as quickly as possible,
without using arms for support. Participants were first
asked to attempt and complete a single sit-and-rise be-
fore beginning the entire chair stand test. Performance
scores for each SPPB individual assessment and a sum-
mary score aggregating the individual assessments were
calculated as per standard SPPB protocol. Each of the
three performance assessments was assigned a categor-
ical score ranging from 0(inability to complete a test)
through 4(highest level of performance) using standard-
ized scoring, and the summary ranging between 0 and
12 was calculated by summing the standing balance, gait
speed, and lower extremity strength categorical scores
[8–10]. Higher scores reflect better lower extremity
function.
T25FW
The T25FW was administered as a measure of walking
speed and has been identified as the best-characterized
objective measure of ambulation in MS based on its
psychometric properties [16]. Participants completed
two trials, and walked as quickly and safely as possible,
and the outcome was the mean of the two walks in feet
per second.
6 MW
The 6 MW was administered as a measure of walking
endurance that is valid and reliable in persons with MS
[15]. Participants completed the 6 MW by walking as
fast and far as possible in a single corridor with two,
180° turns around cones separated by 75 feet. The out-
come was total distance traveled in feet.
MSWS-12
The MSWS-12 is a 12-item patient-rated measure of the
impact of MS on walking [17]. The 12 items on the
MSWS-12 are rated on a scale ranging between 1 (Not
at all) and 5 (Extremely). The total MSWS-12 score
ranges between 0–100 and is computed by summing the
individual item scores, subtracting the minimum pos-
sible score (12), dividing by the maximal score (48), and
then multiplying the result by 100 [6]. Higher scores re-
flect greater perceived walking impairment.
Abbreviated LL-FDI
The functional component of the abbreviated LLFDI
was included as a patient-reported measure of functional
limitations that has been validated in persons with MS
[18]. This outcome contains 15 items that are broken
down into 3 subscales of UEF, BLEF, and ALEF. The 15-
items were rated on a 5-point ordinal scale of 1 (none)
to 5 (cannot do) and were reverse-scored. Scores were
averaged to comprise composite UEF, BLEF, and ALEF
measures. Scores for each five-item subscale range
between 5 and 25, and higher scores reflect fewer func-
tional limitations [18].
Arm curls
Upper extremity muscle strength and endurance was
assessed with a 30-s arm curl test; this is a standard
component of the Senior Fitness Test [23]. Participants
sat near the side of a chair while holding a dumbbell (5
lb for females, and 8 lb for males), and completed as
many arm curls as possible over a 30 s period. The out-
come was number of repetitions performed in 30 s, and
higher values indicate greater arm strength.
Hand grip strength
We further measured upper extremity function based on
hand grip strength using a hand-held dynamom-
eter (Jamar-Hydraulic Hand Dynamometer, Sammons
Preston, Bollingbrook, IL, 60440, USA) [24]. Participants
completed two assessments per hand in an alternating
manner, keeping the arm being tested against the side or
the body with the elbow flexed at 90°, and squeezing the
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hand-held device as hard as possible for 3 s. The outcome
was force generated (i.e., pounds/inch2) per hand, and
higher values indicate greater grip strength.
Procedure
The procedure was approved by the Institutional Review
Board at the University of Illinois, Urbana-Champaign,
and all participants provided written informed consent be-
fore participating in study procedures. The data were col-
lected during one session in a single clinical setting.
Participants underwent a neurological examination by a
Neurostatus Certified examiner for generating EDSS
scores as a description of neurological disability status
[21]. Participants further undertook the SPPB and other
assessments. The order of tests was standardized and
there was seated-rest between the administration of lower
extremity outcomes (e.g., SPPB or T25FW) and upper ex-
tremity outcomes (e.g., arm strength) by completing ‘non-
physically-active’ outcomes (e.g., questionnaires). Partici-
pants received $50 USD for completing the measures.
Data analysis
All data were analyzed in SPSS Statistics, Version
22 (IBM Corporation, Armonk, NY). We provide de-
scriptive characteristics of the measures as median and
interquartile range (IQR). We conducted Spearman rho
rank-order correlations (rs) between SPPB scores and
scores from the other measures. We included only non-
parametric correlations in the event of outliers, non-
normality of distribution, and non-linear associations be-
tween variables [25]. Values for correlation coefficients
of .1, .3, and .5 were interpreted as weak, moderate, and
strong, respectively [26]. We further note that many of
the variables departed from a normal distribution based
on the Shapiro-Wilk test of normality or were ordered-
categorical, and this further justified the approached for
descriptive and correlational analyses.
Results
Sample characteristics
The demographic and clinical characteristics of the
sample are presented in Table 1. The sample had a
median age of nearly 60 years and was primarily
composed of women. The sample had predominantly
relapsing-remitting MS, a median disease duration of
20 years, and moderate MS disability based on the
median EDSS score.
Descriptive characteristics
Descriptive data on the SPPB and measures of lower and
upper extremity function are presented in Table 2. Of
note, the summary SPPB score ranged between 2 and
12, with a median of 9.0 (3.0). The summary SPPB
scores were distributed for the sample as 2.1 % had a
score of 2, 2.1 % had a score of 3, 4.2 % had a score of 4,
4.2 % had a score of 5, 8.3 % had a score of 6, 12.5 %
had a score of 7, 12.5 % had a score of 8, 18.8 % had a
score of 9, 16.7 % had a score of 10, 14.6 % had a score
of 11, and 4.2 % had a score of 12. This indicates 0 %
floor effects, and 4.2 % ceiling effects for summary SPPB
scores in the current sample of older adults with MS.
Convergent and divergent validity
The associations between SPPB scores and measures of
lower and upper extremity function are presented in
Table 3. Regarding convergent validity, SPPB scores
demonstrated strong associations with other measures of
lower extremity function(e.g., |rp| = .64–.82, |rs|
= .66–.79). On the other hand, there were weak associa-
tions with measures of upper extremity function(e.g.,
|rp| = .11–.27, |rs| = .03–.33) suggesting divergent valid-
ity. Scatter plots of associations between SPPB scores
and measures of lower extremity function are provided
in Fig. 1.
Discussion
There are few standard, objective measures for studying
physical function among older adults with MS, yet such
measures are necessary considering the shift in preva-
lence [1, 2] and associated consequences of MS and
older age combined on physical function [4, 6]. We under-
took a preliminary examination of the construct validity of
SPPB scores as an objective measure of lower extremity
function in this segment of the MS population who are
aging with a chronic, disabling neurological disease. Our
preliminary results(i.e., pattern of correlations) provided
Table 1 Demographic and clinical characteristics of the 48
older adults with multiple sclerosis
Variable Descriptive Statistic
Age (years) 59.5 (5.75)
Sex (n, % female) 36, 75 %
MS Type (n, %)
Relapsing-Remitting MS 32, 66.7 %
Secondary Progressive MS 5, 10.4 %
Progressive MS 1, 2.1 %
Unknown/Missing 10, 20.8 %
EDSS score (0–10) 4.5 (2.5)
MS Duration (years) 20.0 (15.0)
Assistive Device Use (n, %)
None 30, 62.5 %
Cane 10, 20.8 %
Walker/Rollator 8, 16.7 %
Note: Data are presented as median (interquartile range), unless indicated
otherwise. MS =multiple sclerosis
EDSS Expanded Disability Status Scale
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evidence for the construct validity of SPPB scores as a
measure of lower extremity function in older adults with
MS. Of note, those older adults with MS who had better
SPPB scores demonstrated faster T25FW performance
and greater 6 MW distance, and reported less walking im-
pairment on the MSWS-12 and fewer lower extremity
functional limitations on the abbreviated LLFDI (i.e., con-
vergent aspects of construct validity). By comparison,
there were weak and/or non-significant associations be-
tween SPPB scores and objective and self-report measures
of upper extremity function (i.e., divergent aspects of con-
struct validity). Collectively, the current results provide
preliminary evidence for the construct validity of SPPB
scores as a measure of lower extremity function in older
adults with MS, and support the possible inclusion of the
SPPB in clinical practice and research involving this grow-
ing demographic of MS.
The median score of 9.0 in the current sample of adults
with MS who had a median age of ~60 years approxi-
mated the mean score estimated for non-disabled,
community-dwelling adults 71 years of age and older(esti-
mated mean = 9.2) [10]. The distribution of SPPB scores
further was consistent with that reported in previous re-
search of non-disabled, community-dwelling older adults
[27]. The median SPPB score in the current study was
below the cut-off value of 10 indicating elevated risk for
developing future disability [10, 27, 28]. Of note, the lower
extremity strength component of the SPPB indicated lar-
ger decrements in physical function than did gait speed or
balance. These data suggest that this sample of older
adults with MS exhibited physical function comparable
with that of a sample of older adults that was one decade
older, and the largest decrement was in lower extremity
strength. Such observations should be confirmed in direct,
head-to-head comparison of older adults with MS and
community-dwelling adults without MS or other neuro-
logical disease.
Of note, the data herein provide a secondary ana-
lysis for establishing preliminary evidence for the
validity of SPPB scores in older adults with MS. The
primary analysis of SPPB scores was undertaken in a
RCT for capturing the effect of a home-based, exer-
cise training intervention targeting strength and
balance that was delivered through DVD on physical
function [19]. The results of the RCT provide evi-
dence for a small, clinically meaningful change in the
SPBB for exercise training compared with control.
Such data may support the responsiveness of the
SPPB for capturing changes in physical function seen
with an exercise training intervention.
There are many possible applications of the SPPB as a
standardized, objective measure for understanding phys-
ical function in older adults with MS. One application in-
volves prospective comparison with other samples of
Table 3 Correlations between SPPB scores and measures of




T25FW .77 (.63, .87)*
6 MW .79 (.65, .87)*
MSWS-12 –.66 (−.46, −.79)*
LLFDI-ALEF .75 (.60, .85)*
LLFDI-BLEF .70 (.52, .82)*
Upper Extremity Function
Arm Curls .33 (.05, .56)*
Grip Strength-R .03 (−.26, .31)
Grip Strength-L .03 (−.26, .31)
LLFDI-UEF .24(−.05, .49)
Note: Values are correlation coefficient (95 % confidence interval). rs
Spearman rho rank-order correlations. *Denotes statistical significance of
correlation coefficient, p < 0.05. SPPB Short Physical Performance Battery,
T25FW Timed 25-Foot Walk, 6 MW 6-min Walk, MSWS-12 Multiple Sclerosis
Walking Scale-12, LLFDI-ALEF Late-Life Function and Disability Instrument,
Advanced Lower Extremity Function Subscale, LLFDI-BLEF Late-Life Function and
Disability Instrument, Basic Lower Extremity Function Subscale, LLFDI-UEF
Late-Life Function and Disability Instrument, Upper Extremity Function Subscale
Table 2 Descriptive characteristics of SPPB scores and measures
of lower and upper extremity function in 48 older adults with
multiple sclerosis
Category Variable Median (IQR)
Primary Outcome
SPPB (0–12) 9.0 (3.0)
Balance (0–4) 4.0 (1.0)
Gait Speed (0–4) 4.0 (1.0)
Lower Extremity Strength (0–4) 1.0 (1.0)
Lower Extremity Function
T25FW (ft/sec) 4.1 (1.7)
6 MW (ft) 1,312 (571)
MSWS-12 (0–100) 65.6 (62.4)
LLFDI-ALEF (0–25) 10.5 (7.0)
LLFDI-BLEF (0–25) 21.0 (7.0)
Upper Extremity Function
Arm Curls (# reps) 12.0 (4.0)
Grip Strength-R (lbs/in2) 59.0 (24.5)
Grip Strength-L (lbs/in2) 56.5 (20.0)
LLFDI-UEF (0–25) 18.5 (5.0)
Note. IQR interquartile range, SPPB Short Physical Performance Battery, T25FW
Timed 25-Foot Walk, 6 MW 6-min Walk, MSWS-12 Multiple Sclerosis Walking
Scale-12, LLFDI-ALEF Late-Life Function and Disability Instrument, Advanced
Lower Extremity Function Subscale, LLFDI-BLEF Late-Life Function and Disability
Instrument, Basic Lower Extremity Function Subscale, LLFDI-UEF Late-Life
Function and Disability Instrument, Upper Extremity Function Subscale
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older adults for understanding the effect of aging in the
context of MS on physical function. Another application
involves the prediction of disability and disease progres-
sion as well as participatory outcomes in older adults with
MS. We envision considerable application of the SPPB in
clinical trials examining the effects of disease modifying
treatments and rehabilitation therapy in older adults with
MS. SPPB scores might even predict intervention re-
sponders (e.g., those who have smaller or larger likelihood
of benefit), and our previous RCT [19] was not designed
nor powered for such an endeavor. There is further value
in the application of the SPPB in clinical practice. The
SPPB could be adopted for characterizing physical func-
tion as well as documenting changes over time. Re-
searchers and clinicians might consider using a recent
virtual SPPB for ongoing measurement of physical func-
tion in older adults with MS [29].
There are important limitations of the current study.
The paper was based on a secondary analysis of data
that were not explicitly collected for the purpose of val-
idating the SPPB. This is a limitation, as we would have
included other measures such as gait, posturography,
falls and falls self-efficacy, and activities of daily living
when validating SPPB scores. The sample was recruited
for a RCT of exercise training, and might have unique
characteristics that restrict the application of the validity
evidence amongst the broader population of older adults
with MS. The sample size was relatively small, and this
might influence the precision of the correlations for val-
idity judgments. The sample further had intact cognitive
function, and many persons ambulated without assistive
devices; these observations further limit broad applica-
tion of the validity evidence for SPPB scores. Such con-
cerns could be overcome based on subsequent research
using a larger sample of older adults who are recruited
for a focal effort on the construct validity of SPPB score
inferences.
Conclusion
We provide preliminary evidence for the validity of the
SPPB as a measure of lower extremity functional per-
formance for inclusion in clinical research and practice
involving older adults with MS.
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